Hirotsugu Isaka - Publications

First- Versus Second- or Subsequent-Line Use of Cyclin-Dependent Kinase 4/6 Inhibitors for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic or Recurrent Breast Cancer: A Multicenter, Retrospective Cohort Study.

Journal: Medicina (Kaunas, Lithuania)

Published: February 20, 2026

Effectiveness of post-mastectomy radiation therapy after breast reconstruction for patients with high-risk breast cancer: A retrospective multicenter cohort study (Reborn study-03).

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 05, 2025

Impact of radiation therapy on breast satisfaction and health-related quality of life after breast reconstruction: a multicenter cross-sectional controlled study (Reborn study-02).

Journal: Breast cancer (Tokyo, Japan)

Published: April 22, 2025

Breast satisfaction and health-related quality of life following total mastectomy, breast-conserving surgery, or immediate breast reconstruction in Japanese patients with breast cancer: multicentre cross-sectional controlled study (Reborn).

Journal: BJS open

Published: April 06, 2025

Long-term results of fluorescence and indigo carmine blue dye-navigated sentinel lymph node biopsy.

Journal: International journal of clinical oncology

Published: October 05, 2020

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B).

Journal: Breast cancer (Tokyo, Japan)

Published: June 24, 2020

Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: March 08, 2019

Risk Factors for Skin Flap Necrosis in Breast Cancer Patients Treated with Mastectomy Followed by Immediate Breast Reconstruction.

Journal: World journal of surgery

Published: November 15, 2018

The Impact of Treatment Preferences in Second-Line Chemotherapy on the Prognosis of HER2-Negative Metastatic Breast Cancer.

Journal: Oncology

Published: January 11, 2017

Histopathologcial and clonal study of combined lobular and ductal carcinoma of the breast.

Journal: Pathology international

Published: November 01, 2012

Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy.

Journal: Breast (Edinburgh, Scotland)

Published: June 11, 2012

Provision of information by pharmacists regarding the effective timing of co-administration of first-generation serotonin receptor antagonists and dexamethasone for chemotherapy-induced nausea and vomiting in patients receiving Doxorubicin and cyclophosphamide chemotherapy for breast cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 14, 2012